$ARIA Recent Headlines Six stocks to watch 4:27 p.m.

New Post Public Reply Private Reply Replies (0) Message Board

Oct 8, 2014 at 9:44 AM

$ARIA Recent Headlines

Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com

ARIAD Gets Breakthrough Therapy Designation for AP26113 - Analyst Blog 5:49 p.m. Oct. 6, 2014 - Zacks.com
Ariad restructures license agreement with Bellicum 9:30 a.m. Oct. 6, 2014 - Seeking Alpha
Wayfair Rises, Westport Innovations Cuts Forecast 8:30 a.m. Oct. 6, 2014 - FOXBusiness
ARIAD Pharmaceuticals' All-In Bet On Europe 11:18 a.m. Oct. 5, 2014 - Seeking Alpha
Free Fall Continues For Freddie Mac, Fannie Mae 12:44 p.m. Oct. 2, 2014 - TheStreet.com
Why Ariad Pharmaceuticals (ARIA) Stock Is Spiking Today 11:23 a.m. Oct. 2, 2014 - TheStreet.com
Markets Mixed; Constellation Brands Posts Downbeat Profit 9:38 a.m. Oct. 2, 2014 - benzinga.com
Ariad cancer med tagged Breakthrough Therapy 9:11 a.m. Oct. 2, 2014 - Seeking Alpha
Morning Market Movers 8:44 a.m. Oct. 2, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – ARIA CLVS THRX MYL 8:00 a.m. Oct. 2, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – CLVS ARIA MYGN CMN 9:15 a.m. Sept. 29, 2014 - InvestorPlace.com
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog 5:55 p.m. Sept. 23, 2014 - Zacks.com
Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit 12:05 p.m. Sept. 19, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/11/14: LULU, ARIA, TITN, RSG 9:58 a.m. Sept. 12, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ISIS ARIA ACAD ALNY 8:00 a.m. Sept. 12, 2014 - InvestorPlace.com
Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte 8:55 a.m. Sept. 5, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA CNC ZMH 7:45 a.m. Sept. 4, 2014 - InvestorPlace.com
'Mad Money' Lightning Round: Yahoo! Is One of the Best Buys Around 6:00 a.m. Sept. 4, 2014 - TheStreet.com
Cramer's Lightning Round - Yahoo Is A Good Steward Of Capital (9/3/14) 5:40 a.m. Sept. 4, 2014 - Seeking Alpha

ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology 7:35 a.m. Oct. 6, 2014 - BusinessWire - BZX
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib 7:35 a.m. Oct. 2, 2014 - BusinessWire - BZX
ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 7:35 a.m. Sept. 29, 2014 - BusinessWire - BZX
INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE 12:41 p.m. Sept. 16, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 1:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress 11:34 p.m. Aug. 6, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel 7:36 a.m. Aug. 5, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results 7:35 a.m. July 16, 2014 - BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe 7:35 a.m. July 14, 2014 - BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 7:30 a.m. June 26, 2014 - PR Newswire - PRF
ARIAD Announces Three Key Appointments to Its Global Management Team 7:35 a.m. June 23, 2014 - BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 9:15 a.m. June 12, 2014 - BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 4:01 p.m. June 11, 2014 - BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting 7:35 a.m. June 11, 2014 - BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors 6:00 a.m. June 4, 2014 - PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors 9:01 a.m. June 1, 2014 - BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 2:16 p.m. May 31, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lennar Unveils Lake Martin Community Homes

Lake Martin's New Residential Offering Step aside, beaches and mountains. Now it's all about lakeside living with some good old Alabama charm. Lennar, a heavyweight in the homebuilding scene, is opening the gates to The Oaks at Eclectic—a fresh batch of single-family homes sprouting near Lake Martin in Eclectic, Alabama. This spot is practically a haven for those who...

Fujifilm's New 400mm Lens: A Game Changer?

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

China Expo Spotlights AI's Role in Future Electronics

AI Tech Takes Center Stage in Qingdao Kicking off the week, the 2026 China International Consumer Electronics Exposition unfolds its grand spectacle in Qingdao. Now, we're not just talking your average tech fare here—this is a heavyweight event with over 300 titans from 12 countries sprawling across a hefty 60,000 square meters. And those are numbers that make people...

CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Tetragon Completes $50M Tender Offer; Shares Prorated

Unpacking Tetragon’s $50 Million Dutch Auction Move If you comb through the smoke-filled corridors of finance, you'll find the name Tetragon Financial Group pacing the latest tender offer rounds. They danced their way through a $50 million 'modified Dutch auction,' snapping up non-voting shares with a kind of ruthless efficiency that only seasoned market players can...

Innovation Drives New Asia-Pacific Opportunities

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

Pentair Faces Class Action Over Fraud Allegations

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

October 15 Marks Prologis Q3 2026 Results Call

Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...

Lupin Gains FDA Nod for Modafinil, Eyes US Market

In the ever-evolving landscape of pharmaceuticals, Lupin Limited's recent triumph snagging FDA approval for their Modafinil Tablets was a move you couldn't miss even if you'd tried. While the rooms of Mumbai and boardrooms around the globe might have been abuzz, investors should tune in to the humming potential of this development—especially if they're navigating the...

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...